RONALD A. REMICK, MD, FRCP(C)
APPENDIX I
Refereed Publications, Book Chapters
Revised – January, 2012
A.
REFEREED PUBLICATIONS/BOOK CHAPTERS
Journals (Total In Press and Published, 1982 to Present: 118)
2010
118.
Joo EJ, Greenwood TA, Schork N, McKinney R, Sadovnick AD, Remick RA, Keck
PE, McElroy SL, Kelsoe JR. Suggestive evidence for linkage of ADHD features in
bipolar disorder to chromosome 10p14. Am J Med Genet B Neuropsychiatr Genet,
2010;153B:260- 268.
2008
117.
Evans LM, Akiskal HS, Greenwood TA, Nievergelt CM, Keck PE Jr, McElroy SL,
Sadovnick AD, Remick RA, Schork NJ, Kelsoe JR. 2008. Suggestive Linkage of a
Chromosomal Locus on 18p11 to Cyclothymic Temperament in Bipolar Disorder
Families. Am J Med Genet Part B 147B: 326–332.
116.
Nievergelt CM, Kripke DF, Barrett TB, Remick RA et al: Suggestive evidence for
association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J
Med Genet B Neuropsychiatr Genet 2006; 141B: 234-241.
115.
Iverson, Grant; Gaetz, Michael; Rzempoluck, Edward; McLean, Peter; Linden,
Wolfgang; Remick, Ronald A New Potential Marker for Abnormal Cardiac
Physiology in Depression.
Journal of Behavioral Medicine 2005; 28: 507511.
114.
Nievergelt CM, Kripke DF, Remick RA, Sadovnick AD, McElroy SL, Keck PE, Kelsoe
Jr. Examination of the clock gene Cryptochrome 1 in bipolar disorder: Mutational
analysis and absence of evidence for linkage or association. Psychiatric Genetics
2005; 15: 45-52.
113.
Evans L, Akiskal HS, Keck PE. McElroy SL, Sadovnick AD, Remick RA, Kelsoe JR.
Familiarity of temperament in bipolar disorder: Support for a genetic spectrum. J
Affective Disorders 2005; 85: 153-168.
112.
Gaetz M, Iverson GL, Linden W, Remick RA, McLean P: The “Randomness” of daynite differences in cardiac physiology are associated with depression. Am. J.
Psychiatry, 2004.
111.
Gaetz MK, Iverson GL, Rzempoluck EJ, Remick RA, Linden W, McLean P: Selforganizing neural network analysis of circadian cardiac data in depression:
Neuropsychobiolgy: 49:30-37, 2004.
2006
2005
2004
110.
Iverson GL, Remick RA: Diagnostic accuracy of the British Columbia Depression
Inventory Psychological Reports 2004: 49: 30-37.
109.
Shaw SH, Mrockowski-Parker Z, Shekhtman T, Alexander M, Remick RA,
Sadovnick AD, McElory SL, Keck Jr. PE, Kelso JR. Linkage of a bipolar
susceptibility locus to human chromosome 13q32 in a new pedigree series.
Molecular Psychiatry: 8:558-564, 2003.
108.
Barrett TB, Hauger RL, Kennedy JL, Sadovnick AD, Remick RA, Keck PE, McElroy
SL, Alexander M, Shaw SH, Kelsoe JR. Evidence that a single nucleotide
polymorphism in the promoter of the G protein receptor kinase 3 gene is associated
with bipolar disorder. Molecular Psychiatry: 8:546-557, 2003.
107.
Cockell SJ, Hewitt PL, Sherry SB, Goldner EM, Fleh GL, Remick RA: Trait and self
presentational dimensions of perfectionism among women with anorexia nervosa.
Cognitive Therapy and Research 2002; 26:745-758.
106.
Remick RA: Diagnosis and treatment of mood disorders in primary care practices –
a clinical update and review. Can. Med. Assoc. J: 167:1253-1260, 2002.
105.
Liang SG, Sadovnick AD, Remick RA, Keck PE, McElroy SL, Kelsoe, JR: A linkage
disequilibrium study of bipolar disorder and microsatellite markers on 22q13.
Psychiatric Genetics: 12:231-235, 2002.
104.
Greenwood TA, Alexander M, Keck PE, McElroy SL, Kelsoe JR. Segmental linkage
disequilibrium within the dopamine transporter gene. Molecular Psychiatry, 7:165173, 2002.
103.
Greenwood TA, Alexander MK, Keck PE, McElroy S, Sadovnick AD, Remick, RA,
Kelsoe, JR: Evidence for linkage disequilibrium between the dopamine transporter
and bipolar disorder. Am J. Med Genet: 105:145-151, 2001
102.
Kelsoe JR, Spence MA, Loetscher E, Sadovnick AD, Remick RA et. al.: A genome
survey indicates a possible susceptibility locus for bipolar disorder on chromosome
22. Proc Nat. Acad. Sci: 98:585-590, 2001.
101.
Goldner EM, Geller J, Birmingham CL, Remick RA: Comparison of Shoplifting
Behaviours in Patients with Eating Disorders, Psychiatric Controls, and Normal
Controls. Can J Psychiatry: 45:471-475, 2000.
100.
Kornberg JR, Brown JL, Sadovnick AD, Remick RA, Keck PE, McElroy SL,
Rappaport MH, Thompson PM, Kaul JB, Vrabel CM, Schommer SC, Wilson T,
Pizzuco D, Jameson S, Shibuk L, Kelsoe JR. Evaluating the parent-of-origin effect
in bipolar affective disorder. Is a more penetrant subtype transmitted paternally? J.
Aff. Dis. 59(3):183-192, 2000.
2003
2002
2001
2000
1999
99.
Striebel K, Beyerstein B, Remick RA et al: Olfactory Identification and Psychosis.
Biol Psychiatry, 1999; 4:1419-1425.
98.
Lapierre YD, Silverstone P, Reesal RT, Saxena B, Turner P, Bakish D, Plamondon
J, Vincent PM, Remick RA, Kroft C, Payeur R, Rosales D, Lam RW, Bologa M: A
Canadian multicenter study of three fixed doses of controlled-release ipsapirone in
outpatients with moderate to severe major depression.
Clinical
Psychopharmacology, 18:268-273, 1998.
97.
Remick RA: Refractory illness in physicians. BC Med J, 1998, 40:153-155.
96.
Lachman HM, Kelsoe JR, Remick RA, Sadovnick AD, Rapaport MH, Lin M, Pazur
BA, Roe AMA, Saito T, Papolos DF: Linkage Studies Suggest a Possible Locus for
Bipolar Disorder Near the Velo-Cardio-Facial Syndrome Region on Chromosome 2
.
Neuropsychiatric Gen, 74:121-128, 1997.
95.
Fournier J-P, Lane RM, Chouinard G, Watson DB, Amin M, Remick RA, Thorpe LU:
A Double-Blind Comparison of Sertraline and Imipramine in Outpatients with Major
Depression: Acute (8 Weeks) and Continuation (16 Weeks) Treatment. Human
Psychopharmacology, Vol 12:203-215, 1997.
94.
Lam RW, Allain S, Sullivan K, Beattie CW, Remick RA, Zis AP: Effects of chronic
lithium treatment on retinal electrophysiologic function. Biological Psychiatry,
41:737-742, 1997.
93.
Kelsoe JR, Loetscher E, Spence MA, Foguet M, Sadovnick AD, Remick RA,
Flodman P, Charara N, Kalkuloglu F, Home J, Masser D, Rapaport MH, Bergesch P,
Mroczkowski-Parker Z, Luebbert H: Evidence for possible genetic linkage of the
dopamine transmitter to bipolar disorder. Am J Med Genet, 74:664-665, 1997.
92.
Kelsoe JR, Sadovnick AD, Kristbjarnarson H, Bergesch P, Mroczkowski-Parker Z,
Drennan M, Rapaport MH, Flodman P, Spence MA, Remick RA: Possible locus for
bipolar disorder near the dopamine transporter on chromosome 5. Neuropsychiatric
Gen, 67:533-540, 1996.
91.
Remick RA, Sadovnick AD, Lam RW, Zis AP, Yee IML: Major depression, minor
depression and double depression - Are they distinct clinical entities?
Neuropsychiatric Gen, 67:347-353, 1996.
90.
Kelsoe JR, Remick RA, Sadovnick AD, Kristbjarnarson, Flodman P, Spence MA,
Morison M, Mroczkowski-Parker Z, Bergesch P, Rapaport MH, Mirow AL, Blakely
RD, Helgason T, Gillin JC, Egeland JA: A genetic linkage study of bipolar disorder
and the serotonin transporter. Neuropsychiatric Gen, 67:215-217, 1996.
89.
Sadovnick AD, Remick RA, Allen J, Swartz E, Yee IML, Eisen K, Farquhar R,
Hashimoto SA, Hooge J, Kastrukoff LF, Morrison W, Nelson J, Oger J, Paty DW:
Depression and Multiple Sclerosis. Neurology, 46:628-632, 1996.
1998
1997
1996
1995
88.
Spence MA, Flodman P, Sadovnick AD, Bailey-Wilson JE, Ameli H, Remick RA:
Bipolar disorder: Evidence for a major locus. Neuropsychiatric Gen, 603:709-716,
1995.
87.
Sadovnick AD, Remick RA, Lam RW, Zis AP, Yee IML, Huggins MJ, Baird PA: A
mood disorder service genetic database: Morbidity risks for mood disorders in 3,942
first-degree relatives of 671 index cases with single depression, recurrent
depression, bipolar I, or bipolar II. Neuropsychiatric Gen, 54:132-140, 1994.
86.
Lam RW, Goldner EM, Solyom L, Remick RA: A controlled study of light therapy for
bulimia nervosa. Am J Psychiatry: 152:744-750, 1994.
85.
Remick RA, Reesal R, Oakander M, Allen J, Claman J, Ramirez CE, Perry K, Keller
FD: Comparison of fluvoxamine and amitriptyline in depressed patients. Curr Ther
Res, 55:243-250, 1994.
84.
Chouinard G, Saxena BM, Nair NPV, Kutcher SP, Bakish D, Bradwejn J,. Kennedy
SH, Sharma V, Remick RA, Kukha-Mohamad SA, Belanger MC, Snaith J, Beauclair
L, Pholman H, D'Souza J: A Canadian multicentre placebo-controlled study of a
fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of
major depression. J of Affective Disorders, 1994; 32: 105-114.
83.
Chouinard G, Saxena BM, Nair NPV, Kutcher SP, Bakish D, Bradwejn J, Kennedy
SH, Sharma V, Remick RA, Kukha-Mohammed SA, Beauclair L, Snaith J, D'Souza
J: Brofaromine in depression: A Canadian multicenter placebo trial and a review of
standard drug comparative studies. Clin Neuropharmacol, 16(2):551-554, 1993.
82.
Remick RA, Sadovnick AD, Gimbarzevsky A, Lam RW, Zis AP, Baird PA, Huggins
MJ: Obtaining a family history - Is it worth the effort? Can J Psychiatry, 38:590-594,
1993.
81.
Remick RA, Claman J, Reesal R, Gibson R, Agbayewa MO, Lam RW, Keller FD: A
comparison between fluoxetine and desipramine in depressed outpatients. Curr
Ther Research, 53(5):457-465, 1993.
80.
Allen JM, Lam RW, Remick RA, Sadovnick AD: Depressive symptoms and family
history in seasonal and non-seasonal mood disorders. Am J Psychiatry, 150(3):443448, 1993.
79.
Chouinard G, Saxena BM, Nair NPV, Kutcher SP, Bakish D, Bradwejn J, Kennedy
SH, Sharma V, Remick RA, Kukha-Mohammed SA, Snaith J, D'Souza J: Efficacy
and safety of brofaromine in depression: A Canadian multicenter placebo-controlled
study. Clin Neuropharm, 15 (Suppl 1, Pt A):426A-427A, 1992.
78.
Zis AP, McGarvey K, Goumeniouk AD, Clark CM, Remick RA, Lam RW: On the
mechanism of ECT-induced prolactin release. Conv Therapy, 8:75-76, 1992.
1994
1993
1992
77.
Zis AP, Goumeniouk AD, Clark CM, Remick RA, Adams SA: ECT-induced PRL
release: A 5-HT1A-Mediated Event? Biol Psychiatry, 31:415-418, 1992.
76.
Bakish D, Bradwejn J, Nair N, McClure J, Remick RA, Bulger I: A comparison of
moclobemide, amitriptyline and placebo in depression: A Canadian multicentre
study. Psychopharmacology, 106:S98-S101, 1992.
75
Lam RW, Buchanan RA, Mador JA, Corral MR, Remick RA: The effects of
ultraviolet-A wavelengths in light therapy for seasonal depression. J Aff Disorders,
24:237-244, 1992.
74.
Remick RA, Lam RW: Prozac - What's all the fuss? BCMJ, 34:31-32, 1992.
73.
Williamson S, Crockett DJ, Hurwitz TA, Remick RA: The processing of emotional
information by depressive and organic patients. Arch Clin Neuropsychiatry, 1991.
72.
Lam RW, Beattie CW, Buchanan RA, Remick RA, Zis AP: Low electrooculographic
ratios in patients with seasonal affective disorder. Am J Psychiatry, 148:1526-1529,
1991.
71.
Lam RW, Buchanan RA, Clark CM, Remick RA: Ultraviolet versus non-ultraviolet
light therapy for seasonal affective disorder. J Clin Psychiatry, 52:213-216, 1991.
70.
Zis AP, Goumeniouk AD, Clark CM, Grant BEK, Remick RA, Lam RW, Garland EJ:
ECT-induced prolactin release: Effect of sex, electrode placement and serotonin
uptake inhibition. Human Psychopharmacology, 6:155-160, 1991.
69.
Lam RW, Fleming JAE, Buchanan A, Remick RA: Seasonal Affective Disorder.
Can Fam Physician, 36:1162-1166, 1990.
68.
Zis AP, Clark CM, Grant BEK, Remick RA, Garland EJ, Lam RW: Effect of naloxone
on afternoon cortisol secretion in depression: A controlled dose-response study. In:
Psychiatry: A World Perspective, Vol. II: Neurosciences in Psychiatry, Biological
Correlates of Mental Disorders, Soldatos CR, Rabavilas AD (EDS), Elsevier,
Amsterdam: pp 298-308, 1990.
67.
Williams KM, Iacono WG, Remick RA, Greenwood P: Dichotic perception and
memory following electroconvulsive treatment for depression. Brit J Psychiatry,
157:366-372, 1990.
66.
Garland EJ, Remick RA, Zis AP: Weight gain with antidepressants and lithium. In:
1990 Year Book of Psychiatry and Applied Mental Health, Talbott JA (ED), Year
Book Medical Publishers Inc., Chicago, Ill, pp. 191-192, 1990.
65.
Remick RA, Froese CL: Monoamine oxidase inhibitors: A clinical review. Can Fam
Phys, 36:1151-1155, 1990.
64.
Wolters EC, Hurwitz TA, Mak E, Teal P, Peppard RF, Remick RA, Calne S, Calne
DB: Clozapine in the treatment of Parkinsonian patients with dopaminomimetic
psychosis. Neurology, 40:832-834, 1990.
1991
1990
1989-1978
63.
Lam RW, Buchanan RA, Remick RA: Seasonal Affective Disorder - A Canadian
Sample. Ann Clin Psychiatry, 1:241-245, 1989.
62.
Zis AP, Remick RA, Clark CM, Goldner EM, Grant BEK, Bernstein M: Evening urine
cortisol excretion and DST results in depression and anorexia nervosa. J Psychiatry
Res, 23(3/4):251-255, 1989.
61.
Remick RA, Keller FD, Gibson RE, Carter D: A comparison between fluoxetine and
doxepin in depressed patients. Cur Ther Res, 46(5):842-848, 1989.
60.
Remick RA: Treatment resistant depression.
14(2):394-396, 1989.
59.
Zis AP, Manji HK, Remick RA, Grant BEK, Clark CM: Effect of 5-HT2 antagonist
ketanserin on the ECT-induced prolactin release. Biol Psychiatry, 26:102-106, 1989.
58.
Zis AP, Remick RA, Clark CM, Goldner E, Grant BEK, Brown GM: Effect of
morphine on cortisol and prolactin secretion in anorexia nervosa and depression.
Clin Endoc, 30:421-427, 1989.
57.
Remick RA, Froese C, Keller FD: Common side effects of monoamine oxidase
inhibitors. Prog Neuropsychiatryopharmacol and Biol Psychiatry, 13:497-504, 1989.
56.
Remick RA, Froese C: Unnecessary delay in tricyclic antidepressant treatment of a
patient with atrial fibrillation. Can Fam Phys, 35:110-112, 1989.
55.
Suedfeld P, Ramirez C, Remick RA, Fleming JAE: Reduction of post-ECT memory
complaints through brief, partial restricted environmental stimulation (REST). Prog
Neuropsychiatryopharmacol and Biol Psychiatry, 13:693-700, 1989.
54.
Zis AP, Remick RA, Clark CM, Grant BEK, Brown GM: Blockade of the postictal
prolactin surge by methysergide. Arch Gen Psychiatry, 46:385-387, 1989.
53.
Garland EJ, Remick RA, Zis AP: Weight gain associated with antidepressants and
lithium. J Clin Psychopharmacol, 8(5):323-330, 1988.
52.
MacEwan GW, Remick RA: Treatment resistant depression. Can J Psychiatry,
33(9):788-792, 1988.
51.
Reinish LW, Remick RA: Neuroleptic malignant syndrome: A case report. Can
Fam Phys, 34:2317-2320, 1988.
50.
Remick RA: Anticholinergic side effects of tricyclic antidepressant and their
management. Prog Neuropsychiatryopharmacol and Biol Psychiatry, 12:225-231,
1988.
49.
Remick RA: An open label study of buspirone in chronic anxiety disorders. Curr
Ther Res, 43:1042-1046, 1988.
48.
Remick RA, Keller FD, Buchanan RA, Gibson RE, Fleming JAE: A comparison of
the efficacy and safety of alprazolam and desipramine in depressed outpatients.
Can J Psychiatry, 33(7):590-594, 1988.
Psychiatry J Univ of Ottawa,
47.
Lam RW, Remick RA: The lateralization of typical facial pain. Can J Psychiatry,
31:100-103, 1988.
46.
Zis AP, Remick RA, Grant BEK, Bernstein M, Grant A: The evening urine cortisol
excretion test in depression. Arch Gen Psychiatry, 44:919-920, 1987.
45.
Remick RA, Jewesson P, Ford RWJ: Monoamine oxidase inhibitors in general
anaesthesia: A re-evaluation. Convulsive Ther, 3:196-203, 1987.
44.
Cockhill L, Remick RA: Blood pressure effects of monoamine oxidase inhibitors The highs and lows. Can J Psychiatry, 32:803-808, 1987.
43.
Suedfeld P, Ramirez C, Remick RA, Fleming JAE: Memory effects of restricted
environmental stimulation therapy (REST) and possible applications to ECT. Prog
Neuropsychiatryopharmacol and Biol Psychiatry, 11:179-184, 1987.
42.
Remick RA: Choosing the right antidepressant. Drug Protocol, 2(6):58-65, 1987.
41.
Heiby EM, Campos PE, Remick RA, Keller FD: Dexamethasone suppression and
self-reinforcement correlates of clinical depression. J Abnormal Psychol, (96,I):7072, 1987.
40.
Bassett AS, Remick RA, Beiser M, Miles JE, Wilt F: Grand Rounds Presentation:
The act of pharmacotherapy in depressed patients. Can J Psychiatry, 31:852-856,
1986.
39.
Bassett AS, Remick RA, Blasberg B: Tardive dyskinesia - an unrecognized cause of
orofacial pain. Oral Surg Oral Med Oral Path, 61:570-572, 1986.
38.
Levy M, Remick RA: Clinical aspects of rapid cycling mood disorders. Can J
Psychiatry, 32:436-441, 1986.
37.
Jewesson PJ, Remick RA: Influence of blood collection tubes on tricyclic
antidepressant concentration. J Clin Psychopharm, 6:51-52, 1986.
36.
Remick RA: Antidepressants - What's New? Can Fam Phys, 32:587-592, 1986.
35.
Jewesson PJ, Remick RA: Clinical application of tricyclic antidepressant serum
levels. BCMJ 27:693-641, 1985.
34.
Lam RW, Remick RA: Pigmentary retinopathy associated with low dose thioridazine
treatment. CMAJ, 132:737, 1985.
33.
Remick RA, Blasberg B: Psychiatric aspects of atypical facial pain. J Can Den
Assn, 12:913-916, 1985.
32.
Remick RA, Howarth BG, Leichner P, Westin JA, Therrien S, Grace M: A multicentre comparison of the efficacy and safety of zimeldine and doxepin in major
depressive disorders. Curr Ther Res, 38:817-825, 1985.
31.
Fleming JAE, Fleetham J, Remick RA: A case report of obstructive sleep apnea in a
patient with bipolar affective disorder. Can J Psychiatry, 30:437-438, 1985.
30.
MacEwan GW, Remick RA, Noone JA: Transdermal scopolamine psychosis Diagnosis and treatment. CMAJ, 133:431-432, 1985.
29.
Remick RA, Fleming JAE, Buchanan RA, Keller FD et al: A comparison of the
safety and efficacy of alprazolam and desipramine in moderately severe depression.
Can J Psychiatry, 30:597-601, 1985.
28.
Remick RA, Lam RW: Alprazolam-induced manic states. J Clin Psychiatry, 46:406407, 1985 (erratum, Journal of Clinical Psychiatry, 46: 541, 1985).
27.
Jewesson PJ, Remick RA, Seccombe D, Godolphin W: Clinical application of
tricyclic antidepressant serum levels: A Canadian experience. Can J Hosp Pharm,
38:156-159, 1985.
26.
Williams KM, Iacono WG, Remick RA: Electrodermal activity among sub-types of
depression. Biol Psychiatry, 20:158-162, 1985.
25.
Kraus RP, Remick RA: Unexpected dexamethasone suppression test results in
delusional vs non-delusional depression. Evidence of distinct clinical entities. J Clin
Psychiatry, 46:188-190, 1985.
24.
Remick RA, Campos PE, Keller FD, Misri S, Loomer F, Westin J: A comparison of
the safety and efficacy of zimeldine and maprotiline in depressed outpatients. Curr
Ther Res, 36:77-85, 1984.
23.
Fleming JAE, Remick RA, Fleetham J: The prevalence of sleep apnea in major
affective disorder. Annals RCSPC, 17:353, 1984.
22.
Blasberg B, Remick RA, Conklin RJ, Keller FD: Atypical facial pain in the elderly. J
of Gerondontology, 3:77-81, 1984.
21.
Kraus RP, Clarke RG, Remick RA: Massive eosinophilic reaction to desipramine in
conjunction with pneumonia. Can J Psychiatry, 29:142-144, 1984.
20.
Kraus RP, Remick RA: The dexamethasone test in psychiatry: Clinical applications
in the diagnosis and management of affective disorders. BCMJ 25(1):26-18, 1983.
19.
Blasberg B, Remick RA, Miles JE: The psychiatric referral in dentistry - indications
and mechanics. Oral Surg Oral Med Oral Path, 56:368-371, 1983.
18.
Remick RA, Barton JS, Patterson B, Campos PE, Miles JE: On so-called treatmentresistant depression. Annals RCPSC, 16:545-548, 1983.
17.
Remick RA, Blasberg B, Barton JS, Campos PE, Miles JE: Ineffective dental and
surgical treatment associated with atypical facial pain. Oral Surg Oral Med Oral
Path, 55:355-358, 1983.
16
Mendel J, Amin M, Chouinard G, Cooper AJ, Remick RA, Miles JE, Saxena B,
Secunda SK, Singh AN: A comparative study of bupropion and amitriptyline in
depressed outpatients. J Clin Psychiatry, 44(Section 2):118-120, 1983.
15.
Remick RA, Blasberg B, Patterson B, Carmichael RP, Miles JE: Clinical aspects of
xerostomia. J Clin Psychiatry, 44:63-65, 1983.
14.
Remick RA, Blasberg B, Campos PE, Miles JE: The psychiatric spectrum
associated with atypical facial pain. Can J Psychiatry, 28:178-181, 1983.
13.
Remick RA, Campos PE, Misri S, Miles JE, Van Wyck-Fleet J: Double-blind
comparison of bupropion HCl with amitriptyline HCl in the treatment of depressed
outpatients. Prog Neuropsychiatryopharmacology, 6:523-527, 1982.
12.
Remick RA, Barton J, Miles JE, Campos PE, Patterson B: On so-called treatmentresistant depression. Annals RCPSC, 15:338, 1982.
11.
Kraus RP, Remick RA: Diazoxide in the management of severe hypertension after
electroconvulsive therapy. Am J Psychiatry, 139:504-505, 1982.
10.
Weaver GB, Remick RA: ECT for depression associated with neurosyphilis: A case
report. J Clin Psychiatry, 43:468-469, 1982.
9.
Remick RA: Current concepts in the management of depression. BCMJ 23:426,
1981.
8.
Remick RA, O'Kane J, Sparling TW: Toxic psychosis with low-dose propranolol
treatment. Am J Psychiatry, 138:850-851, 1981.
7.
Remick RA, Wada JA, Miles JE: Neuropsychiatryiatric and electroencephalographic
aspect in the diagnosis of complex partial seizures. Can Psychiatric Assn J, 26:4952, 1981.
6.
Remick RA, Fine S: Antipsychotic drugs and seizures. J Clin Psychiatry, 40:78-80,
1979.
5.
Remick RA, Wada J: Complex partial and pseudoseizure disorders.
Psychiatry, 136:320-323, 1979.
4.
Shulman R, Remick RA: Sociopharmacology: Medicines in a Social Context, in
Today's Priorities in Mental Health: Knowing and Doing. Edited by M Beiser, R Krell
et al. Symposia Specialists, Miami, 1978, pp 17-20.
3.
Remick RA, Fleming JAE, Kirkpatrick D, Assoc Editors: Today's Priorities in Mental
Health: Knowing and Doing. Edited by M Beiser, R Krell, TY Lin and MH Miller.
Miami, Symposia Specialists, 1978.
2.
Wada JA, Troupin AS, Friel P, Remick RA, Leal K, Pearmain J: A pharmacokinetic
comparison of tablet and suspension dosage forms of carbamazepine. Epilepsia,
19:251-255, 1978.
1.
Remick RA, Miles JE: Carbon monoxide poisoning: neurologic and psychiatric
sequelae. Can Med Assn J, 117:654-655, 1977.
Am J
BOOK CHAPTERS
3
Ralph I, Remick, RA, Burgman NA, (Eds.). In: Psychotropic Agents: A Handbook for
Mental Health Workers, 15th Edition, IGR Publications, 12010.
2.
Remick RA, Sadovnick AD: Depression and suicide in multiple sclerosis. In: Multiple
Sclerosis: Clinical Challenges and Controversies. (Eds.) A.J. Thompson, L. Plaman, R.
Hohlfeld; Martin Dunitz Ltd., London: 1997.
1.
Remick RA: Long term pharmacological treatment of mood disorders. In: Pharmacological
Management of Chronic Psychiatric Disorders. (Eds.) R. Ancill, M. Lader; Balliere Tindall,
London: 1995.